Has Ryan Tsuda, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,063 in general payments to Ryan Tsuda, MD across 221 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Tsuda, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Tsuda, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Tsuda, MD

Interventional Cardiology · Tucson, AZNPI 1528289113

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Abiomed at 44.2% of the total.

$14,063in general payments, 2019–2025

Across 221 payments — averaging $63.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$6K
Medtronic$4K
Abbott$1K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$774
Inari Medical, Inc.$373
Boston Scientific$274
plus $2K from 18 others

$230,803in research payments, 2019–2025

Across 21 payments — averaging $10,991 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$212K
CSL Behring$18K

What the payments were for

Travel & lodging$6455%
Food & beverage$13,41895%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	61	$6,212
Medtronic(2 entities)	64	$3,604
Abbott	23	$1,322
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	26	$774
Inari Medical, Inc.	3	$373
Boston Scientific	4	$274
Acist Medical Systems, Inc.	2	$242
Novartis	13	$203
Penumbra, Inc.	1	$162
Boehringer Ingelheim	4	$155
Terumo Medical Corporation	3	$140
Edwards Lifesciences	1	$137
Recor Medical Inc	2	$107
Asahi Intecc USA, Inc.	1	$74
Philips North America LLC	1	$42
W. L. Gore & Associates, Inc.	1	$33
E.r. Squibb & Sons, L.L.C.	2	$32
Amgen	2	$30
Kestra Medical Technology Services, Inc.	1	$29
B. Braun Interventional Systems Inc.	2	$29
Cvrx, Inc.	1	$27
Novo Nordisk	1	$25
Bayer	1	$23
Baxter Healthcare	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,063 in reported general payments places this provider in the 55th percentile of 223 interventional cardiology providers in Arizona.

See all interventional cardiology providers in Arizona →

Medicare billing

Part B allowed, 2024

$11,333

Medicare patients

Services billed

135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Tucson

Thomas WaggonerTucson$617K
Kapildeo LotunTucson$365K
Neil GheewalaTucson$141K
Dexter de LeonTucson$74K
William ThomasTucson$56K
Ranjith ShettyTucson$50K
Santiago RamirezTucson$45K
Sulaiman RathoreTucson$32K
Michel CorbanTucson$27K
Sundeep ShenoyTucson$24K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →